11/02/2019 17:51:11

MLKCH CEO Dr. Elaine Batchlor receives prestigious James Irvine Foundation Leadership Award

Sacramento, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Dr. Elaine Batchlor, who as CEO of Martin Luther King, Jr. Community Hospital, brought high-quality healthcare to a Los Angeles community with some of the worst health indicators in the nation, will be awarded the James Irvine Foundation Leadership Award in Sacramento today.

The prestigious prize, which comes with a grant of $250,000, recognizes “innovative, effective leaders whose breakthrough solutions to critical state challenges improve people’s lives, create opportunity, and contribute to a better California,” according to the foundation. Dr. Batchlor is one of five Californians – all women – to receive the Leadership Award in 2019.

“We are heartened and inspired by the work of these innovative Californians,” said Don Howard, President and Chief Executive Officer of The James Irvine Foundation. “California’s challenges can sometimes seem insurmountable, so it’s an honor to celebrate these exemplary leaders and elevate the solutions that are improving lives across the state.”

Starting in 2010, Dr. Batchlor spearheaded efforts to open a new, state-of-the-art, 131-bed community hospital in South LA to serve a majority Medi-Cal population. Since its opening in 2015, MLKCH has received accolades for its high patient satisfaction levels, cutting-edge technology and commitment to providing high quality health care both within and outside the hospital’s walls.

Dr. Batchlor, a native of Maryland who received degrees from Harvard, Case Western Reserve and UCLA, was hired in 2010 to lead the effort to bring a hospital back to South LA after the closure of a public hospital, King-Drew Medical Center, in 2007. Batchlor was one of the leaders of a unique public-private partnership in which Los Angeles County funded the new hospital’s infrastructure, UCLA offered physician staffing, and the hospital itself was governed and managed by a private, non-profit team.

Batchlor also spearheaded innovative efforts to expand access to health services by launching a nonprofit medical group – the MLK Community Medical Group.  She found philanthropic partners, including former Microsoft CEO Steve Ballmer, to fund recruitment of top doctors to work in South LA.

South LA residents have high rates of diabetes, heart disease, asthma and other chronic conditions, and few physicians: a 2016 analysis found a physician gap of 1,200 doctors relative to more affluent areas.

Key to Batchlor’s success has been her insistence that MLKCH provide not just good care, but care on par with that provided at hospitals in more affluent areas.

“It’s not enough to provide health care,” Batchlor said. “It is a medical and social imperative to provide excellent health care.  South LA is an area that has been traumatized, marginalized and medically neglected for decades. Our hospital’s focus on quality and access is perceived as an act of social justice.”

Among its accolades, in 2017 MLKCH achieved HIMSS-7, recognizing the highest level of use of health information technology to provide quality care, achieved by only 6.5% in the nation.  It also has one of the lowest C-section rates in the state. In 2017, Politico called MLKCH “the hospital of the future.”

Before assuming the helm of Martin Luther King, Jr. Community Hospital, Dr. Batchlor served on the executive leadership team of L.A. Care Health Plan, the nation’s largest public health plan. As chief medical officer, she was instrumental in developing a quality care delivery model, as well as health information technology, that expanded access and resources to more than a million individuals throughout the county.

Prior to L.A. Care, Dr. Batchlor served in leadership positions at the California HealthCare Foundation, the Los Angeles County Department of Health Services, Prudential Health Care, and Ross Loos Medical Group. Early in her career she served as a clinical instructor at the UCLA School of Medicine.

About The James Irvine Foundation

The James Irvine Foundation is a private, nonprofit grantmaking foundation dedicated to expanding opportunity for the people of California. The Foundation’s current focus is a California where all low-income workers have the power to advance economically. Since 1937 the Foundation has provided more than $1. 87 billion in grants to organizations throughout California. With about $2.3 billion in assets, the Foundation made grants of $9 5.9 million in 2018. For more information about the Irvine Foundation, please visit: www.irvine.org.


Gwen Driscoll

Martin Luther King, Jr. Community Hospital




Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Aug
Da flere skribenter stadig gerne vil beholde tråden for samling af de mange vigtige informationer o..
15 Aug
Det kunne tyde på at nogen mor modtaget receptal, der udviser netop det vi har talt om - at Envarsus..
19 Aug
Endnu en dansk patriark er død. Ære være hans minde.
18 Aug
Da Berlingske Media for cirka 1 år siden overtog Euroinvestor for 23 mio kr, meddelte de, at nu skul..
18 Aug
Fra anden skribent i Veloxis FB gruppen: Børsen side 4, søndag den 18. august. Et uddrag fra e..
19 Aug
En fantastisk dygtig og sympatisk erhvervsmand.  Og en ægte patriot som også betalte sin skat med gl..
16 Aug
14 Aug
Ja, TEVA er jo bare en dårlig historie at købe ind i. I Danmark er aktien (som alle jo ved) primært ..
13 Aug
Til alle dem, som simpelthen ikke kan tro på det der sker lige foran næsen på dem.    Da jeg i sin b..
18 Aug
'83. Det er en god kommentar, iøvrigt har jeg kontaktet DDB i fredags for at høre om de læser recept..


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
Photo Release -- WSFS Bank Welcomes Corynn Ciber in Newly Created Role, Chief Digital Officer
TTM Technologies, Inc. Announces Executive Transition
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Bancorp, Karyopharm, L Brands, and National General and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm
Hagens Berman Investigating SAExploration Holdings (SAEX): Earnings Restatements, SEC Investigation, and Senior Executives Fired

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
20 August 2019 00:24:35
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB5 - 2019-08-20 01:24:35 - 2019-08-20 00:24:35 - 1000 - Website: OKAY